25 XP   0   0   10

Hana Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Hana Pharm Co Ltd together

PenkeI guess you are interested in Hana Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hana Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hana Pharm Co Ltd

I send you an email if I find something interesting about Hana Pharm Co Ltd.

Quick analysis of Hana Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Hana Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩16,068.96
Expected worth in 1 year
₩16,623.19
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
₩554.23
Return On Investment
4.0%

For what price can you sell your share?

Current Price per Share
₩13,860.00
Expected price per share
₩13,290 - ₩14,940
How sure are you?
50%

1. Valuation of Hana Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

₩13,860.00

Intrinsic Value Per Share

₩24,776.43 - ₩29,941.08

Total Value Per Share

₩40,845.38 - ₩46,010.03

2. Growth of Hana Pharm Co Ltd (5 min.)




Is Hana Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$194.5m$180.8m$8.8m4.6%

How much money is Hana Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.9m$4.2m-$345.5k-8.8%
Net Profit Margin9.9%11.5%--

How much money comes from the company's main activities?

3. Financial Health of Hana Pharm Co Ltd (5 min.)




What can you expect buying and holding a share of Hana Pharm Co Ltd? (5 min.)

Welcome investor! Hana Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Hana Pharm Co Ltd.

What can you expect buying and holding a share of Hana Pharm Co Ltd?

First you should know what it really means to hold a share of Hana Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hana Pharm Co Ltd is ₩13,860. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hana Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hana Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩16,068.96. Based on the TTM, the Book Value Change Per Share is ₩138.56 per quarter. Based on the YOY, the Book Value Change Per Share is ₩238.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hana Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.220.0%0.230.0%0.250.0%0.240.0%0.240.0%
Usd Book Value Change Per Share0.160.0%0.100.0%0.170.0%0.560.0%0.560.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.160.0%0.100.0%0.170.0%0.560.0%0.560.0%
Usd Price Per Share9.77-9.94-12.34-14.18-14.18-
Price to Earnings Ratio11.00-11.69-12.56-11.79-11.79-
Price-to-Total Gains Ratio59.52-28.15-5.83-1.97-1.97-
Price to Book Ratio0.87-0.91-1.18-1.48-1.48-
Price-to-Total Gains Ratio59.52-28.15-5.83-1.97-1.97-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.702
Number of shares103
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.56
Usd Total Gains Per Share0.100.56
Gains per Quarter (103 shares)9.9957.93
Gains per Year (103 shares)39.96231.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1040300232222
2080700463454
301201100695686
401601500927918
50200190011591150
60240230013901382
70280270016221614
80320310018541846
90360350020852078
100400390023172310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%19.01.00.095.0%19.01.00.095.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%15.05.00.075.0%15.05.00.075.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.020.00.0%0.00.020.00.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%15.05.00.075.0%15.05.00.075.0%

Fundamentals of Hana Pharm Co Ltd

About Hana Pharm Co Ltd

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-03-25 20:55:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hana Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hana Pharm Co Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.6% means that ₩0.10 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hana Pharm Co Ltd:

  • The MRQ is 9.6%. The company is making a profit. +1
  • The TTM is 9.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.6%TTM9.9%-0.4%
TTM9.9%YOY11.5%-1.6%
TTM9.9%5Y12.3%-2.4%
5Y12.3%10Y12.3%0.0%
1.1.2. Return on Assets

Shows how efficient Hana Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.6% Return on Assets means that Hana Pharm Co Ltd generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hana Pharm Co Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.6%0.0%
TTM1.6%YOY1.8%-0.2%
TTM1.6%5Y2.0%-0.4%
5Y2.0%10Y2.0%0.0%
1.1.3. Return on Equity

Shows how efficient Hana Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.0% Return on Equity means Hana Pharm Co Ltd generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hana Pharm Co Ltd:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.1%-0.1%
TTM2.1%YOY2.4%-0.3%
TTM2.1%5Y2.5%-0.4%
5Y2.5%10Y2.5%0.0%

1.2. Operating Efficiency of Hana Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hana Pharm Co Ltd is operating .

  • Measures how much profit Hana Pharm Co Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hana Pharm Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.5%-8.5%
5Y8.5%10Y8.5%0.0%
1.2.2. Operating Ratio

Measures how efficient Hana Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are ₩1.29 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Hana Pharm Co Ltd:

  • The MRQ is 1.287. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.258. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.258+0.029
TTM1.258YOY1.229+0.028
TTM1.2585Y1.191+0.067
5Y1.19110Y1.1910.000

1.3. Liquidity of Hana Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hana Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.82 means the company has ₩1.82 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Hana Pharm Co Ltd:

  • The MRQ is 1.825. The company is able to pay all its short-term debts. +1
  • The TTM is 1.666. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.825TTM1.666+0.159
TTM1.666YOY2.206-0.540
TTM1.6665Y3.310-1.644
5Y3.31010Y3.3100.000
1.3.2. Quick Ratio

Measures if Hana Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.75 means the company can pay off ₩0.75 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hana Pharm Co Ltd:

  • The MRQ is 0.753. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.703. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.753TTM0.703+0.050
TTM0.703YOY1.006-0.303
TTM0.7035Y2.051-1.348
5Y2.05110Y2.0510.000

1.4. Solvency of Hana Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hana Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hana Pharm Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that Hana Pharm Co Ltd assets are financed with 20.2% credit (debt) and the remaining percentage (100% - 20.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hana Pharm Co Ltd:

  • The MRQ is 0.202. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.217. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.202TTM0.217-0.015
TTM0.217YOY0.234-0.017
TTM0.2175Y0.192+0.025
5Y0.19210Y0.1920.000
1.4.2. Debt to Equity Ratio

Measures if Hana Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 25.3% means that company has ₩0.25 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hana Pharm Co Ltd:

  • The MRQ is 0.253. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.277. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.277-0.024
TTM0.277YOY0.306-0.029
TTM0.2775Y0.240+0.037
5Y0.24010Y0.2400.000

2. Market Valuation of Hana Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Hana Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hana Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.00 means the investor is paying ₩11.00 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hana Pharm Co Ltd:

  • The EOD is 10.927. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.998. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.687. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.927MRQ10.998-0.071
MRQ10.998TTM11.687-0.689
TTM11.687YOY12.564-0.877
TTM11.6875Y11.786-0.099
5Y11.78610Y11.7860.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hana Pharm Co Ltd:

  • The EOD is 16.622. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 16.730. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -47.808. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD16.622MRQ16.730-0.108
MRQ16.730TTM-47.808+64.538
TTM-47.808YOY0.666-48.473
TTM-47.8085Y-131.181+83.374
5Y-131.18110Y-131.1810.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hana Pharm Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.87 means the investor is paying ₩0.87 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Hana Pharm Co Ltd:

  • The EOD is 0.863. Based on the equity, the company is cheap. +2
  • The MRQ is 0.868. Based on the equity, the company is cheap. +2
  • The TTM is 0.908. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.863MRQ0.868-0.006
MRQ0.868TTM0.908-0.040
TTM0.908YOY1.183-0.274
TTM0.9085Y1.480-0.572
5Y1.48010Y1.4800.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hana Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--234.377138.558+69%238.386-2%803.448-71%803.448-71%
Book Value Per Share--16068.95515660.550+3%14933.437+8%14000.443+15%14000.443+15%
Current Ratio--1.8251.666+10%2.206-17%3.310-45%3.310-45%
Debt To Asset Ratio--0.2020.217-7%0.234-14%0.192+5%0.192+5%
Debt To Equity Ratio--0.2530.277-9%0.306-17%0.240+6%0.240+6%
Dividend Per Share----0%-0%-0%-0%
Eps--317.092322.737-2%351.270-10%340.608-7%340.608-7%
Free Cash Flow Per Share--208.45653.763+288%-70.637+134%-40.171+119%-40.171+119%
Free Cash Flow To Equity Per Share--208.45653.763+288%-70.637+134%-40.171+119%-40.171+119%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--29941.080--------
Intrinsic Value_10Y_min--24776.430--------
Intrinsic Value_1Y_max--264.545--------
Intrinsic Value_1Y_min--258.239--------
Intrinsic Value_3Y_max--2879.819--------
Intrinsic Value_3Y_min--2707.222--------
Intrinsic Value_5Y_max--8008.760--------
Intrinsic Value_5Y_min--7254.075--------
Market Cap239771070000.000-1%241328025000.000245739397500.000-2%304903687500.000-21%350349257632.117-31%350349257632.117-31%
Net Profit Margin--0.0960.099-4%0.115-17%0.123-22%0.123-22%
Operating Margin----0%-0%0.085-100%0.085-100%
Operating Ratio--1.2871.258+2%1.229+5%1.191+8%1.191+8%
Pb Ratio0.863-1%0.8680.908-4%1.183-27%1.480-41%1.480-41%
Pe Ratio10.927-1%10.99811.687-6%12.564-12%11.786-7%11.786-7%
Price Per Share13860.000-1%13950.00014205.000-2%17625.000-21%20251.001-31%20251.001-31%
Price To Free Cash Flow Ratio16.622-1%16.730-47.808+386%0.666+2414%-131.181+884%-131.181+884%
Price To Total Gains Ratio59.135-1%59.51928.154+111%5.827+921%1.973+2917%1.973+2917%
Quick Ratio--0.7530.703+7%1.006-25%2.051-63%2.051-63%
Return On Assets--0.0160.016-3%0.018-13%0.020-21%0.020-21%
Return On Equity--0.0200.021-4%0.024-16%0.025-20%0.025-20%
Total Gains Per Share--234.377138.558+69%238.386-2%803.448-71%803.448-71%
Usd Book Value--194589422.041189643779.262+3%180838692.830+8%169547149.461+15%169547149.461+15%
Usd Book Value Change Per Share--0.1640.097+69%0.167-2%0.562-71%0.562-71%
Usd Book Value Per Share--11.24810.962+3%10.453+8%9.800+15%9.800+15%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.2220.226-2%0.246-10%0.238-7%0.238-7%
Usd Free Cash Flow--2524329.913651053.391+288%-855386.966+134%-486438.745+119%-486438.745+119%
Usd Free Cash Flow Per Share--0.1460.038+288%-0.049+134%-0.028+119%-0.028+119%
Usd Free Cash Flow To Equity Per Share--0.1460.038+288%-0.049+134%-0.028+119%-0.028+119%
Usd Market Cap167839749.000-1%168929617.500172017578.250-2%213432581.250-21%245244480.342-31%245244480.342-31%
Usd Price Per Share9.702-1%9.7659.944-2%12.338-21%14.176-31%14.176-31%
Usd Profit--3839877.5453908234.750-2%4253756.379-10%4124763.113-7%4124763.113-7%
Usd Revenue--40164913.47439279948.892+2%36897873.628+9%34137632.098+18%34137632.098+18%
Usd Total Gains Per Share--0.1640.097+69%0.167-2%0.562-71%0.562-71%
 EOD+4 -4MRQTTM+21 -11YOY+15 -175Y+13 -2010Y+13 -20

3.2. Fundamental Score

Let's check the fundamental score of Hana Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.927
Price to Book Ratio (EOD)Between0-10.863
Net Profit Margin (MRQ)Greater than00.096
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.753
Current Ratio (MRQ)Greater than11.825
Debt to Asset Ratio (MRQ)Less than10.202
Debt to Equity Ratio (MRQ)Less than10.253
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.016
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Hana Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.687
Ma 20Greater thanMa 5013,757.000
Ma 50Greater thanMa 10013,738.400
Ma 100Greater thanMa 20013,800.400
OpenGreater thanClose13,930.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  -129,109-14,246-143,355-36,092-179,44716,245-163,201924,098760,897



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets348,386,182
Total Liabilities70,401,294
Total Stockholder Equity277,984,889
 As reported
Total Liabilities 70,401,294
Total Stockholder Equity+ 277,984,889
Total Assets = 348,386,182

Assets

Total Assets348,386,182
Total Current Assets102,420,917
Long-term Assets245,965,265
Total Current Assets
Cash And Cash Equivalents 1,424,616
Short-term Investments 4,734,176
Net Receivables 37,508,930
Inventory 48,347,323
Other Current Assets 83,219
Total Current Assets  (as reported)102,420,917
Total Current Assets  (calculated)92,098,264
+/- 10,322,653
Long-term Assets
Property Plant Equipment 157,841,187
Intangible Assets 14,402,185
Long-term Assets Other 68,900
Long-term Assets  (as reported)245,965,265
Long-term Assets  (calculated)172,312,272
+/- 73,652,993

Liabilities & Shareholders' Equity

Total Current Liabilities56,126,382
Long-term Liabilities14,274,911
Total Stockholder Equity277,984,889
Total Current Liabilities
Short Long Term Debt 23,438,000
Accounts payable 6,447,498
Other Current Liabilities 2,459,399
Total Current Liabilities  (as reported)56,126,382
Total Current Liabilities  (calculated)32,344,897
+/- 23,781,486
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,095,065
Long-term Liabilities Other 1,640,081
Long-term Liabilities  (as reported)14,274,911
Long-term Liabilities  (calculated)4,735,146
+/- 9,539,765
Total Stockholder Equity
Retained Earnings 171,695,338
Total Stockholder Equity (as reported)277,984,889
Total Stockholder Equity (calculated)171,695,338
+/- 106,289,551
Other
Capital Stock8,886,473
Common Stock Shares Outstanding 17,299
Net Debt 22,013,385
Net Invested Capital 301,422,889
Net Working Capital 46,294,535
Property Plant and Equipment Gross 217,855,172



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
252,888,781
261,624,909
264,348,517
263,033,794
270,504,189
266,959,341
275,546,544
276,579,304
282,174,079
281,965,810
284,852,089
303,497,254
335,470,756
329,984,008
337,426,890
345,964,556
342,400,130
344,346,541
348,132,371
348,386,182
348,386,182348,132,371344,346,541342,400,130345,964,556337,426,890329,984,008335,470,756303,497,254284,852,089281,965,810282,174,079276,579,304275,546,544266,959,341270,504,189263,033,794264,348,517261,624,909252,888,781
   > Total Current Assets 
177,306,343
162,310,902
163,683,416
158,888,033
156,477,697
150,205,904
154,690,429
147,794,427
150,713,340
146,274,797
144,936,295
140,454,968
114,549,392
94,690,298
94,460,299
103,527,223
100,282,008
101,555,267
104,850,117
102,420,917
102,420,917104,850,117101,555,267100,282,008103,527,22394,460,29994,690,298114,549,392140,454,968144,936,295146,274,797150,713,340147,794,427154,690,429150,205,904156,477,697158,888,033163,683,416162,310,902177,306,343
       Cash And Cash Equivalents 
20,930,320
3,307,728
3,087,383
14,984,529
10,926,920
11,874,835
13,923,361
20,546,426
20,077,884
12,431,091
5,604,654
6,615,209
3,587,809
5,075,422
785,692
12,548,107
3,907,093
1,304,076
1,382,939
1,424,616
1,424,6161,382,9391,304,0763,907,09312,548,107785,6925,075,4223,587,8096,615,2095,604,65412,431,09120,077,88420,546,42613,923,36111,874,83510,926,92014,984,5293,087,3833,307,72820,930,320
       Short-term Investments 
90,143,832
90,435,127
91,545,173
74,424,597
74,520,000
66,610,000
66,650,000
52,830,000
55,320,000
56,069,825
58,497,578
50,251,154
27,804,744
7,284,176
8,934,176
5,034,176
6,934,176
6,634,176
6,334,176
4,734,176
4,734,1766,334,1766,634,1766,934,1765,034,1768,934,1767,284,17627,804,74450,251,15458,497,57856,069,82555,320,00052,830,00066,650,00066,610,00074,520,00074,424,59791,545,17390,435,12790,143,832
       Net Receivables 
35,090,921
36,882,602
35,337,702
36,217,392
35,988,191
35,142,057
36,691,271
37,661,593
33,728,648
34,275,790
33,511,853
35,250,988
35,289,014
33,372,210
34,401,518
35,675,123
35,510,454
36,319,159
38,726,658
37,508,930
37,508,93038,726,65836,319,15935,510,45435,675,12334,401,51833,372,21035,289,01435,250,98833,511,85334,275,79033,728,64837,661,59336,691,27135,142,05735,988,19136,217,39235,337,70236,882,60235,090,921
       Inventory 
23,871,342
23,578,170
25,369,045
26,886,025
28,884,730
29,797,472
30,315,269
30,729,940
35,029,371
36,529,252
40,005,963
40,692,719
40,271,604
40,401,759
38,984,259
41,403,566
44,726,555
48,013,914
49,256,322
48,347,323
48,347,32349,256,32248,013,91444,726,55541,403,56638,984,25940,401,75940,271,60440,692,71940,005,96336,529,25235,029,37130,729,94030,315,26929,797,47228,884,73026,886,02525,369,04523,578,17023,871,342
       Other Current Assets 
93,833
96,029
97,799
74,830
70,390
77,941
79,415
61,946
62,878
64,195
65,685
57,632
58,311
59,275
60,243
83,797
84,879
85,623
86,734
83,219
83,21986,73485,62384,87983,79760,24359,27558,31157,63265,68564,19562,87861,94679,41577,94170,39074,83097,79996,02993,833
   > Long-term Assets 
75,582,438
99,314,007
100,665,101
104,145,760
114,026,491
116,753,437
120,856,115
128,784,877
131,460,739
135,691,013
139,915,793
163,042,286
220,921,364
235,293,710
242,966,592
242,437,333
242,118,122
242,791,275
243,282,255
245,965,265
245,965,265243,282,255242,791,275242,118,122242,437,333242,966,592235,293,710220,921,364163,042,286139,915,793135,691,013131,460,739128,784,877120,856,115116,753,437114,026,491104,145,760100,665,10199,314,00775,582,438
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
154,235,048
151,868,053
157,053,602
157,494,422
157,171,221
157,841,187
157,841,187157,171,221157,494,422157,053,602151,868,053154,235,04800000000000000
       Goodwill 
0
0
0
0
0
0
0
0
3,883,447
0
3,781,251
0
0
0
0
0
0
0
0
0
0000000003,781,25103,883,44700000000
       Intangible Assets 
5,319,376
5,319,376
5,432,576
5,479,976
5,628,945
5,876,445
6,173,862
7,974,757
7,962,507
12,431,471
8,216,644
12,837,449
12,707,003
12,576,557
12,511,511
11,990,065
12,761,153
12,877,137
14,025,691
14,402,185
14,402,18514,025,69112,877,13712,761,15311,990,06512,511,51112,576,55712,707,00312,837,4498,216,64412,431,4717,962,5077,974,7576,173,8625,876,4455,628,9455,479,9765,432,5765,319,3765,319,376
       Long-term Assets Other 
79,314
80,909
82,371
62,723
59,460
64,619
66,110
51,384
52,170
53,678
54,926
48,348
49,282
49,963
50,780
69,985
70,695
71,409
71,913
68,900
68,90071,91371,40970,69569,98550,78049,96349,28248,34854,92653,67852,17051,38466,11064,61959,46062,72382,37180,90979,314
> Total Liabilities 
46,010,537
48,403,654
50,042,281
42,702,232
51,394,384
42,163,659
42,244,473
44,197,791
53,761,883
44,247,528
40,048,443
51,596,171
86,484,029
75,305,851
76,124,735
77,567,636
80,705,754
74,277,346
74,202,092
70,401,294
70,401,29474,202,09274,277,34680,705,75477,567,63676,124,73575,305,85186,484,02951,596,17140,048,44344,247,52853,761,88344,197,79142,244,47342,163,65951,394,38442,702,23250,042,28148,403,65446,010,537
   > Total Current Liabilities 
37,555,105
40,828,604
41,119,518
33,658,040
42,011,759
32,684,835
32,439,100
34,237,483
43,661,465
34,224,254
30,492,285
40,844,899
54,821,369
43,050,430
42,566,368
44,704,055
67,898,882
61,585,250
61,202,184
56,126,382
56,126,38261,202,18461,585,25067,898,88244,704,05542,566,36843,050,43054,821,36940,844,89930,492,28534,224,25443,661,46534,237,48332,439,10032,684,83542,011,75933,658,04041,119,51840,828,60437,555,105
       Short-term Debt 
3,162,533
13,445,686
12,932,694
2,680,678
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,680,67812,932,69413,445,6863,162,533
       Short Long Term Debt 
3,162,533
13,445,686
12,932,694
2,680,678
2,615,351
2,587,407
2,549,748
2,446,800
2,293,840
2,240,143
2,086,190
8,397,448
11,658,380
10,477,257
10,848,986
10,444,623
23,584,347
26,323,942
26,782,000
23,438,000
23,438,00026,782,00026,323,94223,584,34710,444,62310,848,98610,477,25711,658,3808,397,4482,086,1902,240,1432,293,8402,446,8002,549,7482,587,4072,615,3512,680,67812,932,69413,445,6863,162,533
       Accounts payable 
6,636,290
5,611,548
6,200,126
6,938,415
7,170,524
6,138,329
6,592,765
6,032,407
6,598,652
6,442,672
6,236,228
6,677,617
7,032,679
6,651,071
6,416,977
8,063,545
9,239,813
8,414,579
8,611,367
6,447,498
6,447,4988,611,3678,414,5799,239,8138,063,5456,416,9776,651,0717,032,6796,677,6176,236,2286,442,6726,598,6526,032,4076,592,7656,138,3297,170,5246,938,4156,200,1265,611,5486,636,290
       Other Current Liabilities 
2,129,991
2,210,841
2,226,980
2,164,617
1,976,776
2,207,009
2,254,143
2,322,537
2,248,915
2,344,056
2,377,199
2,460,774
2,466,236
2,488,828
2,532,245
2,468,241
2,491,015
2,516,010
2,587,820
2,459,399
2,459,3992,587,8202,516,0102,491,0152,468,2412,532,2452,488,8282,466,2362,460,7742,377,1992,344,0562,248,9152,322,5372,254,1432,207,0091,976,7762,164,6172,226,9802,210,8412,129,991
   > Long-term Liabilities 
8,455,432
7,575,050
8,922,764
9,044,193
9,382,625
9,478,824
9,805,373
9,960,308
10,100,418
10,023,274
9,556,157
10,751,271
31,662,660
32,255,421
33,558,368
32,863,581
12,806,872
12,692,097
12,999,908
14,274,911
14,274,91112,999,90812,692,09712,806,87232,863,58133,558,36832,255,42131,662,66010,751,2719,556,15710,023,27410,100,4189,960,3089,805,3739,478,8249,382,6259,044,1938,922,7647,575,0508,455,432
       Long term Debt 
1,414,130
754,941
600,668
446,800
293,840
177,148
86,190
0
0
0
0
0
20,000,000
20,000,000
20,000,000
20,000,000
0
0
0
0
000020,000,00020,000,00020,000,00020,000,0000000086,190177,148293,840446,800600,668754,9411,414,130
       Capital Lease Obligations 
990,772
1,095,162
2,542,203
2,327,371
2,211,941
1,989,896
2,216,334
2,052,303
1,923,848
1,941,744
2,059,004
2,377,340
2,496,168
2,654,015
4,103,662
3,655,099
3,640,139
3,396,509
3,314,802
3,095,065
3,095,0653,314,8023,396,5093,640,1393,655,0994,103,6622,654,0152,496,1682,377,3402,059,0041,941,7441,923,8482,052,3032,216,3341,989,8962,211,9412,327,3712,542,2031,095,162990,772
       Long-term Liabilities Other 
1,501,647
1,531,818
1,559,505
1,456,526
1,366,672
1,485,232
1,519,516
1,525,839
1,547,005
2,755,052
1,628,678
1,666,588
1,701,016
1,726,660
1,757,090
1,676,169
1,693,706
1,712,899
1,761,283
1,640,081
1,640,0811,761,2831,712,8991,693,7061,676,1691,757,0901,726,6601,701,0161,666,5881,628,6782,755,0521,547,0051,525,8391,519,5161,485,2321,366,6721,456,5261,559,5051,531,8181,501,647
> Total Stockholder Equity
206,878,244
213,221,255
214,306,236
220,331,561
219,109,805
224,795,682
233,302,071
232,381,512
228,412,196
237,718,282
244,803,646
251,901,084
248,986,727
254,678,157
261,302,155
268,396,921
261,694,376
270,069,195
273,930,279
277,984,889
277,984,889273,930,279270,069,195261,694,376268,396,921261,302,155254,678,157248,986,727251,901,084244,803,646237,718,282228,412,196232,381,512233,302,071224,795,682219,109,805220,331,561214,306,236213,221,255206,878,244
   Common Stock00000000000000000000
   Retained Earnings 
93,069,012
100,172,173
107,752,508
114,131,975
112,186,663
116,933,156
125,245,327
121,132,874
119,859,691
128,571,338
136,315,614
143,064,260
140,338,075
146,201,829
151,669,908
159,224,090
155,712,419
163,423,351
167,248,582
171,695,338
171,695,338167,248,582163,423,351155,712,419159,224,090151,669,908146,201,829140,338,075143,064,260136,315,614128,571,338119,859,691121,132,874125,245,327116,933,156112,186,663114,131,975107,752,508100,172,17393,069,012
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 00000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue224,456,851
Cost of Revenue-84,872,489
Gross Profit139,584,362139,584,362
 
Operating Income (+$)
Gross Profit139,584,362
Operating Expense-197,425,402
Operating Income27,031,449-57,841,040
 
Operating Expense (+$)
Research Development7,404,003
Selling General Administrative55,253,985
Selling And Marketing Expenses0
Operating Expense197,425,40262,657,988
 
Net Interest Income (+$)
Interest Income274,894
Interest Expense-897,409
Other Finance Cost-897,408
Net Interest Income274,893
 
Pretax Income (+$)
Operating Income27,031,449
Net Interest Income274,893
Other Non-Operating Income Expenses0
Income Before Tax (EBT)27,906,95627,031,449
EBIT - interestExpense = -897,409
22,332,770
23,230,179
Interest Expense897,409
Earnings Before Interest and Taxes (EBIT)028,804,365
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax27,906,956
Tax Provision-5,574,186
Net Income From Continuing Ops22,332,77022,332,770
Net Income22,332,770
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-274,893
 

Technical Analysis of Hana Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hana Pharm Co Ltd. The general trend of Hana Pharm Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hana Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hana Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 14,040 < 14,170 < 14,940.

The bearish price targets are: 13,520 > 13,330 > 13,290.

Tweet this
Hana Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hana Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hana Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hana Pharm Co Ltd. The current macd is 35.37.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hana Pharm Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hana Pharm Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hana Pharm Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hana Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHana Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hana Pharm Co Ltd. The current adx is 11.56.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hana Pharm Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hana Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hana Pharm Co Ltd. The current sar is 13,483.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hana Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hana Pharm Co Ltd. The current rsi is 52.69. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Hana Pharm Co Ltd Daily Relative Strength Index (RSI) ChartHana Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hana Pharm Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hana Pharm Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hana Pharm Co Ltd Daily Stochastic Oscillator ChartHana Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hana Pharm Co Ltd. The current cci is 71.90.

Hana Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartHana Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hana Pharm Co Ltd. The current cmo is 6.39920689.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hana Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHana Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hana Pharm Co Ltd. The current willr is -34.61538462.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hana Pharm Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hana Pharm Co Ltd Daily Williams %R ChartHana Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hana Pharm Co Ltd.

Hana Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hana Pharm Co Ltd. The current atr is 200.53.

Hana Pharm Co Ltd Daily Average True Range (ATR) ChartHana Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hana Pharm Co Ltd. The current obv is -81,844.

Hana Pharm Co Ltd Daily On-Balance Volume (OBV) ChartHana Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hana Pharm Co Ltd. The current mfi is 70.05.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hana Pharm Co Ltd Daily Money Flow Index (MFI) ChartHana Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hana Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Hana Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hana Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.687
Ma 20Greater thanMa 5013,757.000
Ma 50Greater thanMa 10013,738.400
Ma 100Greater thanMa 20013,800.400
OpenGreater thanClose13,930.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hana Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hana Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hana Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hana Pharm Co Ltd

I send you an email if I find something interesting about Hana Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hana Pharm Co Ltd.

Receive notifications about Hana Pharm Co Ltd in your mailbox!